Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

Add Yahoo as a preferred source to see more of our stories on Google. Many of us are painfully aware of our body's increasing number of shortcomings as we get older. Sagging skin, hearing loss, ...

Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and ...

Quitting smoking and getting regular eye exams may lower your risk of macular degeneration. Eating a Mediterranean diet can reduce your risk of advanced AMD by 41%. You can wear sunglasses that block ...

ORLANDO, Florida — Achieving target glucose and lipid levels reduces the risk for diabetic retinopathy (DR) and other adverse health outcomes in people with diabetes, but all are associated with a ...

New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two therapies recently approved to treat dry age-related macular degeneration ...

Macular degeneration and glaucoma can both lead to vision loss. However, macular degeneration tends to affect central vision while glaucoma affects side vision. The causes and treatment are also ...

Macular degeneration and macular dystrophy are eye conditions affecting the center of the retina. Although they share overlapping symptoms, their root causes and treatments differ. Macular ...

Recurrent exudations in patients with exudative age-related macular degeneration (eAMD) can be sufficiently monitored with macular thickness maps alone. Recurrent exudation in patients with exudative ...

Macular degeneration is the leading cause of vision loss in people older than 65. Smoking doubles your risk of macular degeneration compared to non-smokers. Your risk of the disease increases if you ...

Weaker handgrip strength is linked to higher AMD incidence, with a stronger association observed in women compared to men. The study used UK Biobank data, excluding participants under 50 or with ...

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...